Nanovis' new spinal implant technology may reduce antibiotic resistance — here's how

Written by Shayna Korol | April 19, 2018 | Print  |

Nanovis received FDA clearance for its FortiCore PLIF and TLIF spinal interbodies with nanosurface features.

Here are five things to know.

1. The chair of Boston-based Northeastern University's chemical engineering department and chemical engineering professor Thomas Webster, PhD, designed the implant's nanofeatures.

2. The implants have a nanosurface-enhanced deeply porous titanium scaffold intermolded with a PEEK core.

3. Dr. Webster and his team used the same chemistry Nanovis utilized to create its existing spinal implant, changing only the texture of the implant's surface to emulate bone on the nanoscale.

4. Dr. Webster said the nanofeature technology could be to other devices, such as knee and hip implants or screws used in the lower legs.

5. The implants' surface features make it difficult for bacteria to attach, reducing the risk of infection. Preventing implant-associated infection reduces the need for antibiotics and antibiotic overuse has led to the rise of antibiotic-resistant bacteria, a major public health concern that has caused more than 23,000 deaths, according to the CDC.

More articles on surface technology:

4 things to know about Stratasys

6 things to know about generative design, the process NuVasive uses for spinal implants

4 key points on surface treatment for spinal implants


© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months